Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-15

Clinical Trial Update: Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of capecitabine and vorinostat with radiation therapy in nonmetastatic pancreatic cancer has completed, focusing on saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Vorinostat (vorinostat)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Pancreatic Cancer, Periampullary Adenocarcinoma | Phase 1 | Status: COMPLETED